logo

For the Inventor, By the Inventor

Ascot, United Kingdom

Actimed Therapeutics Limited

USPTO Granted Patents = 11


Trademarks = 1

Forward Citations = 2

Loading Chart...
Loading Chart...

13 inventors (with patents filed for the assignee):

goldMedal Stefan Anker (9 out of 16 patents)

silverMedal Andrew J S Coats (8 out of 8 patents)

bronzeMedal Jochen Springer (7 out of 9 patents)

4.  Ronnie Maxwell Lawrence (2 out of 16 patents)

5.  Saurabh Chitre (1 out of 3 patents)

6.  Andrew Js Coats (1 out of 2 patents)

7.  Jonathan James Loughrey (1 out of 13 patents)

8.  Jaclyn Raeburn (1 out of 2 patents)

9.  Natalie Louise Kelk (1 out of 3 patents)

10.  Kiara Marissa Lobato (1 out of 1 patent)

11.  Andrew Justin Stewart Coats (1 out of 1 patent)

12.  Elaine Morten (1 out of 1 patent)

13.  Robin Chandra Bhattacherjee (1 out of 1 patent)

14.  Craig Callahan (1 out of 1 patent)

15.  Melissa Joseph (1 out of 1 patent)


11 patents:

1. 12721826 - Salt of a pharmaceutical compound (2026-09-01),
2. 12303474 - S-enantiomerically enriched compositions of beta blockers for treating amyotrophic lateral sclerosis (2025-05-20),
3. 12109192 - Organic acid addition salts of S-pindolol (2024-10-08),
4. 11938102 - S-enantiomerically enriched compositions of beta blockers for treating amyotrophic lateral sclerosis (2024-03-26),
5. 11433036 - Oxprenolol compositions for treating cancer (2022-09-06),
6. 11382876 - S-enantiomerically enriched compositions of beta blockers for treating muscle weakness (2022-07-12),
7. 11096908 - S-enantiomerically enriched compositions of beta blockers for treating muscle weakness (2021-08-24),
8. 11007158 - S-enantiomerically enriched compositions of beta blockers for treating amyotrophic lateral sclerosis (2021-05-18),
9. 10828270 - Oxprenolol compositions for treating cancer (2020-11-10),
10. 10449166 - S-enantiomerically enriched compositions of beta blockers for treating amyotrophic lateral sclerosis (2019-10-22),
11. 10398658 - Oxprenolol compositions for treating cancer (2019-09-03),
Company Overview
Actimed Therapeutics Limited is a biotechnology company based in Ascot, UK, specializing in the development of innovative therapeutics for the treatment of metabolic and neurodegenerative disorders. The company focuses on advancing its proprietary drug candidates through rigorous research and clinical development, leveraging a deep understanding of the underlying biological mechanisms. Actimed aims to address significant unmet medical needs by harnessing its expertise in drug formulation and delivery, contributing to improved patient outcomes.
Profile summary synthesized from public USPTO records and patent filings.

logo

Company Badge

USPTO Data Jan 1 1976 - Oct 20 2026

11 Patents

#1 in Ascot

#1,600 in United Kingdom

#51,801 in the World

Ascot, GB
Ascot, United Kingdom

Actimed Therapeutics Limited

Forward Citations = 2

13 inventors:

goldMedal Stefan Anker (9 out of 16 patents)

silverMedal Andrew J S Coats (8 out of 8 patents)

bronzeMedal Jochen Springer (7 out of 9 patents)

4.  Ronnie Maxwell Lawrence (2 out of 16 patents)

5.  Saurabh Chitre (1 out of 3 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Actimed Therapeutics Limited. Retrieved from https://idiyas.com/company/actimed-therapeutics

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…